Use of Xarelto Expanded to Treat Blood Clots

Published November 5, 2012

Use of Xarelto Expanded to Treat Blood Clots

Filed under: drug treatment programs washington dc

Washington, D.C. – infoZine – The U.S. Food and Drug Administration expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following …
Read more on Kansas City infoZine

Synribo Approve for Chronic Myelogenous Leukemia

Filed under: drug treatment programs washington dc

Washington, D.C. – infoZine – The U.S. Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease. An estimated 5,430 … Synribo is approved under …
Read more on Kansas City infoZine

Marijuana's Recreational, Medical Use on Ballots in Six States

Filed under: drug treatment programs washington dc

Marijuana advocates have placed measures on ballots in six states dealing with the recreational or medical use of the drug, defying federal efforts to crack down on use where it's already legal. … “There would be some signal there to Washington, D.C …
Read more on Businessweek